In recognition of the University of Arizona Cancer Center’s promising junior investigators, the American Cancer Society (ACS) has awarded the Center a $360,000 Institutional Research Grant (IRG).
Cutting-edge research investigating the genetic basis for devastating disorders in the critically ill – acute respiratory distress syndrome (ARDS) and ventilator-induced lung injury (VILI) – will receive a major boost thanks to an $11.4 million, five-year program project grant.
Donna Zhang, PhD, professor in the Department of Pharmacology and Toxicology at the University of Arizona College of Pharmacy, is the principal investigator on two new R01 grants from the National Institutes of Health that will provide more than $3 million for her research.
Bone marrow transplants (BMT) will be the main topic at the next Open House at the UA Cancer Center – North Campus, 3838 N. Campbell Ave., on Monday, Aug. July 28, 5-7 p.m. The theme of the event is “BMT & Multiple Myeloma.”
The following news items are from the University of Arizona Arthritis Center, through which the UA Division of Rheumatology largely operates:
The University of Arizona is among 18 institutions participating in a $28 million, five-year Martin Delaney Collaboratory grant awarded today to George Washington University by the National Institutes of Health (NIH) to marshal various immunotherapy advances to create a novel HIV cure strategy.
The University of Arizona Health Sciences and Banner Health have been awarded a $4 million grant from the National Institutes of Health to participate in the Precision Medicine Initiative® Cohort Program, which aims to enroll 1 million or more U.S. participants to improve prevention and treatment of disease based on individual differences in lifestyle, environment and genetics.
